Literature DB >> 15053813

Effect of high-salt diet or chronic captopril treatment on exercise capacity in normotensive rats.

Naoyoshi Minami1, Nobuyoshi Mori, Makoto Nagasaka, Taku Harada, Hajime Kurosawa, Masayuki Kanazawa, Masahiro Kohzuki.   

Abstract

1. We investigated whether chronic suppression of the renin-angiotensin system, which is known to be associated with reductions in microvascular density and vasodilator responsiveness of skeletal muscle, could affect exercise capacity in normotensive rats. 2. Rats were placed on normal rat chow, normal rat chow with captopril (100 mg/kg per day) or a high-salt diet (HS; 4%) for 4 weeks. Following these interventions, rats with indwelling carotid artery catheters were submitted to stepwise increasing exercise on a motor treadmill at a speed of 10, 20 and 30 m/min for 4 min while blood lactate was measured. 3. Blood lactate after exercise at a speed of 20 m/min was significantly higher and the duration during which rats were able to run at a speed of 30 m/min was significantly shorter in captopril-treated rats and rats fed an HS diet compared with control rats. 4. We conclude that chronic treatment with captopril or HS diet could reduce the exercise capacity in inactive normotensive rats, probably through chronic inhibition of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053813     DOI: 10.1111/j.1440-1681.2004.03980.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

1.  Inhibition of angiogenesis by high salt diet is associated with impaired muscle performance following chronic muscle stimulation.

Authors:  Matthew C Petersen; Andrew S Greene
Journal:  Microcirculation       Date:  2008-07       Impact factor: 2.628

Review 2.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

3.  Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease.

Authors:  Katrina J Curtis; Victoria M Meyrick; Bhavin Mehta; Gulam S Haji; Kawah Li; Hugh Montgomery; William D-C Man; Michael I Polkey; Nicholas S Hopkinson
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

4.  A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.

Authors:  Dinesh Shrikrishna; Rebecca J Tanner; Jen Y Lee; Amanda Natanek; Amy Lewis; Patrick B Murphy; Nicholas Hart; John Moxham; Hugh E Montgomery; Paul R Kemp; Michael I Polkey; Nicholas S Hopkinson
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.